FDA Inspection 1342670 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3012288516

The FDA completed an inspection of Octapharma Plasma, Inc. on Oct 15, 2026 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Oct 15, 2026
Fiscal Year
2027
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dallas, TX (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.